Hernia Mesh Devices Market By Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia, Umbilical Hernia, and Others), Mesh Type (Biologic Mesh and Synthetic Mesh), Procedure (Open Surgery and Laparoscopic Surgery), End User (Hospitals, Ambulatory Surgical Centers, and Others) and Geography  

Hernia Mesh Devices Market Size is valued at USD 5.2 billion in 2021 and is poised to grow at a significant CAGR of 3.2% over 2022–2028. A hernia occurs when an internal organ protrudes through a weak spot of muscle or connective tissue and generally occurs within the abdominal cavity, between the chest and the hips. The most common types of hernias are inguinal, femoral, and incisional. Most hernias are caused by pressure and weak spot of muscle or connective tissue causes by some defect at birth or later. An increase in abdominal pressure can cause a hernia, including obesity, lifting heavy objects, diarrhea or constipation, or persistent coughing or sneezing. However, poor nutrition, smoking, and overexertion can weaken muscles and can be a cause of a hernia. The increase in the prevalence of hernia is the leading factor in the hernia mesh devices market growth due to smoking, harsh lifestyle, poor nutrition, genetic factors, and other factors. According to a report, Abdominal wall hernias are common, with a prevalence of 1.7% for all ages and 4% for those older than 45 years. Inguinal hernias account for 75% of abdominal wall hernias, with a lifetime risk of 27% in men and 3% in women. With the prevalence of hernia, the rise in demand for advanced technology and reimbursement policies supported by the government is expected to maintain the global hernia mesh devices market trend. However, the high cost of meshes and inconsistency in reimbursement in economic countries are restraining the hernia mesh devices market growth. Geographically, the hernia mesh devices market is segmented into North America, Europe, Asia Specific, Latin America, and MEA countries. North America is holding the highest global hernia mesh devices market share in 2021 and is expected to dominate the market in the upcoming years due to the high adoption rate of surgical meshes as a treatment option.   Recent Market Developments: In Aug 2022, AI startup Abridge secured $12.5M and launched an enterprise medical transcription solution to ease provider burnout. In April 2022, Ariste Medical received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its drug-embedded, synthetic hernia mesh in the United States.